Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Metab Brain Dis
Asıl Yazarlar: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://ncbi.nlm.nih.gov/pubmed/27525431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller